Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Collegium Pharmaceutical, Inc (COLL)  
$37.30 0.28 (0.76%) as of 4:30 Tue 5/7


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 41,504,000
Market Cap: 1.55(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $21.06 - $40.91
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  625
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Collegium Pharmaceutical is a pharmaceutical company. Co.'s portfolio includes: Xtampza ER, Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol. Xtampza ER was approved by the U.S. Food and Drug Administration for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. Nucynta ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy in adults. Nucynta IR is indicated for the management of acute pain severe enough to require an opioid analgesic.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 10,995 133,280 276,351 867,449
Total Sell Value $400,850 $4,028,847 $7,154,366 $20,637,629
Total People Sold 2 4 4 6
Total Sell Transactions 2 8 13 39
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 391
  Page 6 of 16  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Santini Gino Director   –       •      –    2021-05-20 4 A $0.00 $0 D/D 9,941 44,136     -
   Melincoff Gwen A Director   –       •      –    2021-05-20 4 A $0.00 $0 D/D 9,941 20,948     -
   Heffernan Michael Thomas Director   –       •      –    2021-05-20 4 A $0.00 $0 D/D 9,941 13,988     -
   Freund John Gordon Director   –       •      –    2021-05-20 4 A $0.00 $0 D/D 9,941 20,948     -
   Kuhlmann Shirley R. EVP and General Counsel   •       –      –    2021-05-10 4 AS $22.77 $159,390 D/D (7,000) 89,990 -10%     
   Fleming Alison B Chief Technical Officer   •       –      –    2021-03-30 4 A $0.00 $0 D/D 5,984 154,737     -
   Kuhlmann Shirley R. EVP and General Counsel   •       –      –    2021-03-16 4 D $24.69 $18,122 D/D (734) 96,990     -
   Heffernan Michael Thomas Director   –       •      –    2021-03-15 4 AS $25.26 $1,266,774 D/D (50,075) 4,047 1%     
   Ciaffoni Joseph President and CEO   •       •      –    2021-03-01 4 AS $22.56 $1,468,425 D/D (64,768) 278,307 -2%     
   Ciaffoni Joseph President and CEO   •       •      –    2021-03-01 4 OE $8.22 $399,624 D/D 48,616 343,075     -
   Fleming Alison B Chief Technical Officer   •       –      –    2021-03-01 4 AS $23.36 $140,417 D/D (6,011) 148,753 -2%     
   Dreyer Scott EVP & Chief Commercial Officer   •       –      –    2021-02-11 4 AS $24.89 $199,132 D/D (7,898) 83,258 -6%     
   Kuhlmann Shirley R. EVP and General Counsel   •       –      –    2021-02-10 4 D $25.95 $152,015 D/D (5,858) 97,724     -
   Ciaffoni Joseph President and CEO   •       •      –    2021-02-10 4 D $25.95 $617,247 D/D (23,786) 294,459     -
   Dreyer Scott EVP & Chief Commercial Officer   •       –      –    2021-02-10 4 D $25.95 $134,525 D/D (5,184) 91,156     -
   Malamut Richard EVP and Chief Medical Officer   •       –      –    2021-02-10 4 D $25.95 $59,685 D/D (2,300) 96,677     -
   Brannelly Paul Executive Vice President & CFO   •       –      –    2021-02-10 4 D $25.95 $220,341 D/D (8,491) 215,428     -
   Fleming Alison B Chief Technical Officer   •       –      –    2021-02-10 4 D $25.95 $185,387 D/D (7,144) 156,164     -
   Kuhlmann Shirley R. EVP and General Counsel   •       –      –    2021-01-20 4 AS $24.45 $148,680 D/D (6,081) 103,582 -1%     
   Fleming Alison B Chief Technology Officer   •       –      –    2021-01-19 4 A $0.00 $0 D/D 51,889 163,308     -
   Ciaffoni Joseph President and CEO   •       •      –    2021-01-19 4 A $0.00 $0 D/D 133,989 318,245     -
   Malamut Richard EVP and Chief Medical Officer   •       –      –    2021-01-19 4 A $0.00 $0 D/D 39,147 98,977     -
   Dreyer Scott EVP & Chief Commercial Officer   •       –      –    2021-01-19 4 A $0.00 $0 D/D 51,945 96,340     -
   Brannelly Paul Executive Vice President & CFO   •       –      –    2021-01-19 4 A $0.00 $0 D/D 50,161 223,919     -
   Kuhlmann Shirley R. EVP and General Counsel   •       –      –    2021-01-19 4 A $0.00 $0 D/D 52,132 109,663     -
  391 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 16
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us